Searchable abstracts of presentations at key conferences in endocrinology

ea0029p765 | Endocrine Disruptors | ICEECE2012

Changes of hemostatic variables during cross-sex hormone treatment in transsexual people.

Sanchez-Pacheco M. , Mijares-Zamuner M. , Negueruela-Avellan G. , Segura L. , Marco P. , Pico-Alfonso A. , Moreno-Perez O.

Introduction: Cross-sex hormone treatment (CHT) in male-to-female (M2F) transsexuals affects the hemostatic balance, with the emergence of a prothrombotic state with the use of certain estrogen (oral ethinyl estradiol vs 17β estradiol). Testosterone administration to F2M transsexuals had an antithrombotic effect. In female-to-male in (F2M) transsexuals administration of testosterone seems to carry a mild antithrombotic effect.Objective: To quantify ...